BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18044384)

  • 1. Acinetobacter baumannii in casualties returning from Afghanistan.
    Stuart TL; Mulvey M; Simor AE; Tien HC; Battad A; Taylor G; Vayalumkal JV; Weir C; Ofner M; Gravel D; Paton S
    Can J Infect Control; 2007; 22(3):152-4. PubMed ID: 18044384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.
    Durante-Mangoni E; Zarrilli R
    Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.
    Scott P; Deye G; Srinivasan A; Murray C; Moran K; Hulten E; Fishbain J; Craft D; Riddell S; Lindler L; Mancuso J; Milstrey E; Bautista CT; Patel J; Ewell A; Hamilton T; Gaddy C; Tenney M; Christopher G; Petersen K; Endy T; Petruccelli B
    Clin Infect Dis; 2007 Jun; 44(12):1577-84. PubMed ID: 17516401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq.
    Jones A; Morgan D; Walsh A; Turton J; Livermore D; Pitt T; Green A; Gill M; Mortiboy D
    Lancet Infect Dis; 2006 Jun; 6(6):317-8. PubMed ID: 16728314
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into acinetobacter war-wound infections, biofilms, and control.
    Dallo SF; Weitao T
    Adv Skin Wound Care; 2010 Apr; 23(4):169-74. PubMed ID: 20299843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(45):1063-6. PubMed ID: 15549020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers.
    Tien HC; Battad A; Bryce EA; Fuller J; Mulvey M; Bernard K; Brisebois R; Doucet JJ; Rizoli SB; Fowler R; Simor A
    BMC Infect Dis; 2007 Aug; 7():95. PubMed ID: 17697345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey.
    Munoz-Price LS
    J Hosp Infect; 2015 Apr; 89(4):254-8. PubMed ID: 25766464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal characterization of Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and methicillin-resistant Staphylococcus aureus colonizing and infecting combat casualties.
    Sensenig RA; Murray CK; Mende K; Wolf SE; Chung KK; Hospenthal DR; Yun HC
    Am J Infect Control; 2012 Mar; 40(2):183-5. PubMed ID: 21802175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the incidences of multidrug-resistant and extensively drug-resistant organisms isolated in a military medical center.
    Keen EF; Murray CK; Robinson BJ; Hospenthal DR; Co EM; Aldous WK
    Infect Control Hosp Epidemiol; 2010 Jul; 31(7):728-32. PubMed ID: 20500036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of antimicrobial-resistant Acinetobacter in hospitals.
    Pitt T
    Nurs Stand; 2007 May 9-15; 21(35):51-6. PubMed ID: 17515153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter in modern warfare.
    O'Shea MK
    Int J Antimicrob Agents; 2012 May; 39(5):363-75. PubMed ID: 22459899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating a cohort area to limit transmission of pandrug-resistant Acinetobacter baumannii in a Thai tertiary care center.
    Apisarnthanarak A; Warren DK; Fraser VJ
    Clin Infect Dis; 2009 May; 48(10):1487-8. PubMed ID: 19374565
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
    Markogiannakis A; Fildisis G; Tsiplakou S; Ikonomidis A; Koutsoukou A; Pournaras S; Manolis EN; Baltopoulos G; Tsakris A
    Infect Control Hosp Epidemiol; 2008 May; 29(5):410-7. PubMed ID: 18419362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.
    Mihu MR; Martinez LR
    Virulence; 2011; 2(2):97-102. PubMed ID: 21321482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and control of nosocomial infections for multi-drug resistant Acinetobacter baumannii].
    Jpn J Antibiot; 2010 Oct; 63(5):368-70. PubMed ID: 21268409
    [No Abstract]   [Full Text] [Related]  

  • 17. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
    Maragakis LL; Perl TM
    Clin Infect Dis; 2008 Apr; 46(8):1254-63. PubMed ID: 18444865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervention to limit transmission of extremely drug-resistant Acinetobacter baumannii in patients who underwent surgery.
    Apisarnthanarak A; Warren DK
    Clin Infect Dis; 2013 Oct; 57(8):1215-6. PubMed ID: 23825356
    [No Abstract]   [Full Text] [Related]  

  • 19. Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
    Perez F; Ponce-Terashima R; Adams MD; Bonomo RA
    Virulence; 2011; 2(2):86-90. PubMed ID: 21499025
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
    López-Rojas R; Smani Y; Pachón J
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):231-3. PubMed ID: 23458763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.